Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study-Reference-Cited by-同舟云学术

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study

Published:2019-09-30 Issue:20 Volume:134 Page:1708-1711
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Visco Carlo¹²^ORCID,Rodeghiero Francesco¹³,Romano Alessandra⁴,Valeri Federica⁵,Merli Michele⁶^ORCID,Quaresimini Giulia⁷,Volpetti Stefano⁸,Santi Roberto M.⁹^ORCID,Carli Giuseppe¹,Lucchini Elisa⁸¹⁰,Passamonti Francesco⁶,Rambaldi Alessandro⁷,Motta Giovanna⁴,Borchiellini Alessandra⁵,d’Amore Emanuele S. G.¹¹,Ruggeri Marco¹

Affiliation:

1. Division of Hematology, San Bortolo Hospital, Vicenza, Italy;

2. Department of Medicine, Section of Haematology, University of Verona, Verona, Italy;

3. Hematology Project Foundation, Vicenza, Italy;

4. Hematology, University Hospital, Catania, Italy;

5. Hematology and Oncology, Città della Salute e della Scienza, Torino, Italy;

6. Department of Medicine and Surgery, University of Insubria, Varese, Italy;

7. Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy;

8. Hematology and Bone Marrow Transplant Unit, University Hospital, Udine, Italy;

9. Hematology, SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy;

10. Department of Haematology, University Hospital, Trieste, Italy; and

11. Institute of Pathology, San Bortolo Hospital, Vicenza, Italy

Abstract

Visco and colleagues report excellent response to eltrombopag in immune thrombocytopenia in the setting of chronic lymphoproliferative disease.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/134/20/1708/1506044/bloodbld2019001617.pdf

Reference24 articles.

1. Clinical updates in adult immune thrombocytopenia;Lambert;Blood,2017

2. Treatment of immune thrombocytopenia in adults: the role of thrombopoietin-receptor agonists;Rodeghiero;Semin Hematol,2015

3. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura;Bussel;N Engl J Med,2007

4. Immune thrombocytopenia in lymphoproliferative disorders;Visco;Hematol Oncol Clin North Am,2009

5. The ITP syndrome: pathogenic and clinical diversity;Cines;Blood,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is splenectomy a good strategy for refractory immune thrombocytopenia in adults?;British Journal of Haematology;2023-09-21

2. Clinical Care Team’s Guide for Awareness on Risk Assessment of Eltrombopag Complicating Acute Kidney Injury in Relapsed Immune Thrombocytopenic Patients: A Case Report;Medicina;2023-09-11

3. Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients;Pharmaceuticals;2023-08-29

4. The efficacy and safety of eltrombopag in treating TKI-induced thrombocytopenia in patients with chronic myeloid leukemia;Hematology;2023-08-22

5. Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration;Journal of Clinical and Experimental Hematopathology;2023